BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 19290853)

  • 1. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
    Hudić I; Fatusić Z
    J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
    Kalinka J; Szekeres-Bartho J
    Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor.
    Hudić I; Szekeres-Bartho J; Fatušić Z; Stray-Pedersen B; Dizdarević-Hudić L; Latifagić A; Hotić N; Kamerić L; Mandžić A
    J Reprod Immunol; 2011 Dec; 92(1-2):103-7. PubMed ID: 22032897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone-induced blocking factor and cytokine profile in women with threatened pre-term delivery.
    Hudić I; Fatusić Z; Szekeres-Bartho J; Balić D; Polgar B; Ljuca D; Dizdarević-Hudić L
    Am J Reprod Immunol; 2009 May; 61(5):330-7. PubMed ID: 19343831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome.
    Polgár B; Nagy E; Mikó E; Varga P; Szekeres-Barthó J
    Biol Reprod; 2004 Nov; 71(5):1699-705. PubMed ID: 15269099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of dydrogesterone supplementation on serum cytokine profile in women with threatened abortion.
    Kalinka J; Radwan M
    Am J Reprod Immunol; 2006 Feb; 55(2):115-21. PubMed ID: 16433830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
    Raghupathy R; Al-Mutawa E; Al-Azemi M; Makhseed M; Azizieh F; Szekeres-Bartho J
    J Reprod Immunol; 2009 Jun; 80(1-2):91-9. PubMed ID: 19371956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage.
    Raghupathy R; Al Mutawa E; Makhseed M; Azizieh F; Szekeres-Bartho J
    BJOG; 2005 Aug; 112(8):1096-101. PubMed ID: 16045524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influences of active immunotherapy on T helper cell type 1 and 2 cytokines in women with unexplained habitual abortion].
    Dong RY; Kong BH; Xu YX; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):362-5. PubMed ID: 12895381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Urinary and Serum Progesterone-Induced Blocking Factor in Women with Preterm Birth.
    Hudić I; Szekeres-Bartho J; Stray-Pedersen B; Fatušić Z; Polgar B; Ećim-Zlojutro V
    J Reprod Immunol; 2016 Sep; 117():66-9. PubMed ID: 27479613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cytokines during early pregnancy in women with recurrent spontaneous abortion: decreased TNF-alpha levels in abortion with normal chromosome karyotype.
    Yamada H; Morikawa M; Furuta I; Kato EH; Shimada S; Sata F; Kishi R; Minakami H
    Hokkaido Igaku Zasshi; 2004 May; 79(3):237-41. PubMed ID: 15188632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.
    Walch K; Hefler L; Nagele F
    J Matern Fetal Neonatal Med; 2005 Oct; 18(4):265-9. PubMed ID: 16318978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of relationship between T helper cell type-1 and type-2 cytokines and intrahepatic cholestasis of pregnancy].
    Peng B; Liu S
    Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):516-8. PubMed ID: 12411008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetric outcome and cytokine levels in threatened miscarriage.
    Calleja-Agius J; Schembri-Wismayer P; Calleja N; Brincat M; Spiteri D
    Gynecol Endocrinol; 2011 Feb; 27(2):121-7. PubMed ID: 20500112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage?
    Ku CW; Allen JC; Malhotra R; Chong HC; Tan NS; Østbye T; Lek SM; Lie D; Tan TC
    Gynecol Endocrinol; 2015; 31(8):647-51. PubMed ID: 26036717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on changes of serum T helper cell type 1 and 2 cytokines after active immunotherapy in women with unexplained habitual abortion].
    Qiu L; Lin Q; Hong Y
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jul; 36(7):408-10. PubMed ID: 11718026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of total flavones from Cuscuta chinensis on expression of Th type-1/Th type-2 cytokines, serum P and PR in abortion rats model].
    Ma HX; You ZL; Wang RG
    Zhong Yao Cai; 2008 Aug; 31(8):1201-4. PubMed ID: 19112902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth.
    Hudić I; Stray-Pedersen B; Szekeres-Bartho J; Fatušić Z; Dizdarević-Hudić L; Tomić V; Polgar B; Hadžiefendić B; Fatušić J
    J Reprod Immunol; 2015 Jun; 109():36-40. PubMed ID: 25818991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum progesterone-induced blocking factor at 11-13 weeks' gestation in spontaneous early preterm delivery.
    Beta J; Szekeres-Bartho J; Skyfta E; Akolekar R; Nicolaides KH
    Fetal Diagn Ther; 2011; 29(3):197-200. PubMed ID: 21212635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome.
    Vitoratos N; Papadias C; Economou E; Makrakis E; Panoulis C; Creatsas G
    Mediators Inflamm; 2006; 2006(4):30485. PubMed ID: 17047289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.